RNTX
Rein Therapeutics·NASDAQ
--
--(--)
--
--(--)
RNTX fundamentals
Rein Therapeutics (RNTX) released its earnings on Nov 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.21 (YoY +22.22%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.21
+22.22%
Report date
Nov 14, 2025
EPS
Actual | -4.8 | -2.8 | -2.6 | -2.4 | -1.6 | -1.2 | -1.4 | -1.6 | -1.8 | -1.8 | -1.4 | -0.4 | -1.54 | -0.86 | -0.45 | -0.27 | -1.89 | -0.25 | -0.28 | -0.21 | |||||||||
Forecast | -4.05 | -3.75 | -2.5 | -2.5486 | -1.35 | -1.4667 | -1.4 | -1.6 | -1.5333 | -1.7 | -1.65 | -0.4 | -0.2 | -0.1637 | -0.14 | -0.2256 | -0.245 | -0.3 | -0.21 | -0.22 | -0.24 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -18.52% | +25.33% | -4.00% | +5.83% | -18.52% | +18.18% | 0.00% | 0.00% | -17.39% | -5.88% | +15.15% | 0.00% | -100.00% | -840.75% | -514.29% | -99.47% | -10.20% | -530.00% | -19.05% | -27.27% | +12.50% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Rein Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Rein Therapeutics's earnings call?What is the market's earnings forecast for Rein Therapeutics next quarter?What is Rein Therapeutics's gross profit margin?What guidance did Rein Therapeutics's management provide for the next earnings period?Did Rein Therapeutics beat or miss consensus estimates last quarter?What does Rein Therapeutics do and what are its main business segments?What factors drove the changes in Rein Therapeutics's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
